Havas Health & You network expands global innovation offering
In response to the growing need for data and technology-based solutions in the health and wellness categories, Havas Health & You (HH&Y) has expanded its offerings. The network has appointed Philippe Huot-Louradour to the newly created position of European technology and innovation lead. David Hunt has been appointed global chief digital officer, adding to his role as CEO of HH&Y West.
In their new roles, according to network executives, Hunt and Huot-Louradour will continue to drive the quickly growing innovation agenda of the company, including tapping into the existing technology, digital and data capabilities and resources of the HH&Y agencies globally, and within Havas and Vivendi, to build bespoke teams and services customized to client needs.
According to Hunt, the former leader of Havas Lynx, “Our intention is to deliver the right innovation, at the right time, for the right brief, leveraging our suite of unparalleled technology and data services. We have incredible innovation assets around the world, from AI to product innovation teams and more. When added to the assets within Vivendi and broader Havas, it makes for a very compelling proposition. Leading the EU and joining our global team, Philippe will play a critical role across Europe to better health outcomes by driving and leveraging this innovation.”
“We already have great digital capabilities within our individual European agencies,” says John Hackney, CEO of HH&Y Europe. “Philippe will be able to orchestrate that appropriately, while harnessing the greater technology capabilities of the Havas and Vivendi Groups, to drive best in class innovation that contributes to our global agenda.”
Huot-Louradour brings more than 15 years of health and digital experience to the position, having previously held the position of managing director at Havas digital agency Full Six, setting up Full Six Health and more recently, as managing director of Havas Health Paris.
“This is a fantastic opportunity,” says Huot-Louradour. “Meaningful innovation lies at the core of Havas Group’s strategy and should be more pragmatic in health and wellness, definitively dedicated to help patients and HCP’s to manage pathologies. We believe that the pharma industry is now clearly ready to go further in their ‘beyond the pill‘ strategies and that technology will lead the health and wellness categories moving forward.”
According to HH&Y Global CEO Donna Murphy, “Our innovation practice globally is a key competitive advantage for us and will be an even deeper focus moving forward. The impact of technology and data as it relates to health and wellness cannot be understated, and David and Phillipe bring profound expertise to help drive our offering in the EU and around the globe.”
